Navigation Links
Specialty Renal Pharmacy Delivers One Millionth Prescription
Date:8/27/2008

DaVita Rx brings convenience and personalized care to dialysis patients

nationwide

DALLAS, Aug. 27 /PRNewswire-FirstCall/ -- DaVita Inc., a leading provider of kidney care services, announced today that its specialty renal pharmacy, DaVita Rx(SM), will deliver its one millionth prescription. The prescription will be filled today during a special celebration at DaVita Rx headquarters in Dallas. DaVita(R) Senior Vice President Gina Randolph and DaVita Vice President of Clinical Support Services Dr. David Van Wyck are on hand while the prescription is packaged for distribution.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

DaVita Rx is a pharmacy specializing in the needs of people on dialysis, offering the convenience of dialysis center delivery service at no additional cost along with personalized care to make sure patients are able to receive and take all the medications they need. The Dallas location is its flagship pharmacy, and along with two other pharmacies, it serves over 13,000 dialysis patients in 33 states.

"I had trouble with pharmacies not having my medication ready when I went to pick it up, or my medication being out of stock, or going and they were closed," says a local dialysis patient who uses DaVita Rx. "With DaVita Rx I get it when I need it and I feel healthier."

On average, dialysis patients are prescribed more than eight medications to treat five co-morbid conditions. Research indicates dialysis patients adhere to the medication regimen prescribed by their doctors at a rate of 50-60%. DaVita Rx pharmacists work with DaVita's clinical teammates to drive medication adherence and improve patient outcomes and provides physicians with clear visibility of their patients' medication adherence. With that partnership in place, adherence rates can be 80% or higher.

DaVita Rx also provides kidney patients with an auto-refill program, flexible payment options, help with insurance and 24/7 toll-free access to DaVita Rx pharmacists.

DaVita Rx's one millionth prescription will be delivered to a dialysis center in Los Angeles, Calif. today by DaVita CEO Kent Thiry.

DaVita and DaVita Rx are trademarks or registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 107,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education and its community programs, please visit http://www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Specialty Surgery Center to Partner With Surgical Care Affiliates
2. Most Influential Events for Koreas Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November
3. More Cancer Lymph Nodes Analyzed at Specialty Centers
4. HighPoint Solutions Signs Deal to Implement Model N Managed Care and Government Pricing System for Specialty Pharmaceutical Company
5. Baldor Specialty Foods, Inc. Responds to FDA Tomato Recall
6. Tri-anim and Bound Tree Medical Merge to Create Nations Leading Specialty Health Care Distributor
7. U.S.News & World Report Debuts First Specialty Rankings of Americas Best Childrens Hospitals
8. Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
9. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
10. OBGManagement.com and Convera(R) Launch Search Site for Physicians in the ObGyn Specialty
11. ACP hosts largest medical education meeting for general and subspecialty internists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: